Julie Gilmore is the Vice President and Global Head of Lilly Gateway Labs, a shared innovation lab with locations in the US, Asia and Europe, designed to speed the discovery of innovative medicines through collaboration with local biotech companies. She joined Eli Lilly after receiving her Doctorate in Membrane Biophysics from Purdue University and her Postdoctoral Fellowship in Drug Transport from Indiana University School of Medicine. During her 20-year plus career at Lilly, Julie has held several leadership and scientific positions across research and drug development. Julie is on the Board of Directors of Mozart Therapeutics, IgGenix, and the Board of Trustees of Franklin College.